metabolic disease

Ultrasound detects abdominal fat linked to metabolic diseases

February 10, 2026 / Clinical Practice / InnovateMed Author / metabolic disease

by University of Rovira i Virgili edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain The distribution of body fat, and particularly fat accumulated around the abdomen, is a determining factor in the risk of developing metabolic and cardiovascular diseases. However, not all abdominal fat has the […]

Ultrasound detects abdominal fat linked to metabolic diseases Read More »

Cholesterol buildup in liver fat droplets directly drives fibrosis in metabolic disease, study finds

July 30, 2025 / Research update / InnovateMed Author / cholesterol, fibrosis, metabolic disease

by Jordan Shaked, Yale University edited by Lisa Lock, reviewed by Robert Egan Packing defects on the lipid droplet surface under phosphatidylcholine (PC) deficiency compared to phosphatidylethanolamine (PE). Accumulation of free cholesterol on the surface of hepatic lipid droplets under PC deficiency may contribute to the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis

Cholesterol buildup in liver fat droplets directly drives fibrosis in metabolic disease, study finds Read More »

Key mechanisms of enzyme involved in rare metabolic disease identified

July 9, 2025 / Research update / InnovateMed Author / metabolic disease

by CIC bioGUNE edited by Gaby Clark, reviewed by Robert Egan 3D-Structure of HsCBS. (Top) Schematic representation of the HsCBS domain organization. The heme-binding site is shown in red, the catalytic core (resembling the PLP-fold type II family) is highlighted in yellow, and the Bateman module is depicted in blue. (Middle) HsCBS monomer in its basal (left)

Key mechanisms of enzyme involved in rare metabolic disease identified Read More »

Tracking microbial rhythms reveals new target for treating metabolic diseases

June 18, 2025 / Research update / InnovateMed Author / metabolic disease

Researchers harness the benefits of time-restricted feeding on the gut microbiome, with the ultimate goal of developing new therapies for obesity, diabetes, and related diseases Peer-Reviewed Publication University of California – San Diego image: Researchers used metatranscriptomics to measure the daily rhythms of gut bacteria to better understand the metabolic benefits of time-restricted feeding. view more

Tracking microbial rhythms reveals new target for treating metabolic diseases Read More »

Ultrasound detects abdominal fat linked to metabolic diseases

Cholesterol buildup in liver fat droplets directly drives fibrosis in metabolic disease, study finds

Key mechanisms of enzyme involved in rare metabolic disease identified

Tracking microbial rhythms reveals new target for treating metabolic diseases

Need Help?

We are here to help.